Wenzhen Ge, PhD

Regeneron Pharmaceuticals
Greenwich, Connecticut, United States

Regeneron Pharmaceuticals, Inc (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Real-World Treatment Patterns Before and After Receiving PD-L1 Test Results in Patients with Advanced Non-small Cell Lung Cancer (aNSCLC)

  Sunday, August 28, 2022
  2:15 PM – 2:30 PM CEST